An official website of the United States government
Cancer Screening Prevalence and Associated Factors Among US Adults
Cancer is the second leading cause of death in the United States, only exceeded by heart disease; 1,708,921 new cancer cases were reported and 599,265 people died of cancer in 2018. Although age-adjusted cancer incidence decreased 9.5% over the last 20 years, the number of people diagnosed with cancer increased. The estimated national expenditures for cancer care in the United States were $208.9 billion in 2020, a 10% increase from 2015, mainly because of the aging and growth of the US population. In future years, costs will likely increase as the population ages and as new and often more expensive treatments are adopted as standards of care.
About 30% to 50% of cancers diagnosed today could be prevented by reducing exposure to tobacco smoke and other environmental carcinogens, maintaining healthy body weight, and receiving recommended cancer screenings and vaccinations. Screening can detect cancer before symptoms occur and at earlier stages when the disease is more treatable. It also can detect precancerous conditions, which can be treated to prevent cancer from occurring. Understanding cancer screening patterns and factors associated with getting screened helps public health policy makers and practitioners improve cancer prevention programs by implementing evidence-based policies and practices. The 11 articles in this special collection from Preventing Chronic Disease present research on cancer screening trends, determinants of cancer screening, and public health practices that increase cancer screening uptake in specific populations. Guest editors for this collection are Zhen-Qiang (Marshall) Ma, MD, MPH, MS, division director of community epidemiology at the Pennsylvania Department of Health, and Lisa C. Richardson, MD, MPH, director of the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention.
GUEST EDITORIAL
PEER REVIEWED
Cancer Screening Prevalence and Associated Factors Among US Adults
Ma Z, Richardson LC. Cancer Screening Prevalence and Associated Factors Among US Adults. Prev Chronic Dis 2022;19:220063.
GIS SNAPSHOTS
PEER REVIEWED
Richardson LC, King JB, Thomas CC, Richards TB, Dowling NF, Coleman King S. Adults Who Have Never Been Screened for Colorectal Cancer, Behavioral Risk Factor Surveillance System, 2012 and 2020. Prev Chronic Dis 2022;19:220001.
ORIGINAL RESEARCH
PEER REVIEWED
Cancer Incidence Projections in the United States Between 2015 and 2050
Weir HK, Thompson TD, Stewart SL, White MC. Cancer Incidence Projections in the United States Between 2015 and 2050. Prev Chronic Dis 2021;18:210006.
ORIGINAL RESEARCH
PEER REVIEWED
Sharma KP, Grosse SD, Maciosek MV, Joseph D, Roy K, Richardson LC, et al. Preventing Breast, Cervical, and Colorectal Cancer Deaths: Assessing the Impact of Increased Screening. Prev Chronic Dis 2020;17:200039.
ORIGINAL RESEARCH
PEER REVIEWED
Benavidez GA, Zgodic A, Zahnd WE, Eberth JM. Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States. Prev Chronic Dis 2021;18:200315.
ORIGINAL RESEARCH
PEER REVIEWED
Racial Residential Segregation and Colorectal Cancer Mortality in the Mississippi Delta Region
Kruse-Diehr AJ, McDaniel JT, Lewis-Thames MW, James AS, Yahaya M. Racial Residential Segregation and Colorectal Cancer Mortality in the Mississippi Delta Region. Prev Chronic Dis 2021;18:200483.
ORIGINAL RESEARCH
PEER REVIEWED
Bhimla A, Mann-Barnes T, Park H, Yeh M, Do P, Aczon F, et al. Effects of Neighborhood Ethnic Density and Psychosocial Factors on Colorectal Cancer Screening Behavior Among Asian American Adults, Greater Philadelphia and New Jersey, United States, 2014–2019. Prev Chronic Dis 2021;18:210062.
ORIGINAL RESEARCH
PEER REVIEWED
Zhan FB, Morshed N, Kluz N, Candelaria B, Baykal-Caglar E, Khurshid A, et al. Spatial Insights for Understanding Colorectal Cancer Screening in Disproportionately Affected Populations, Central Texas, 2019. Prev Chronic Dis 2021;18:200362.
ORIGINAL RESEARCH
PEER REVIEWED
Rohatgi KW, Marx CM, Lewis-Thames MW, Liu J, Colditz GA, James AS. Urban–Rural Disparities in Access to Low-Dose Computed Tomography Lung Cancer Screening in Missouri and Illinois. Prev Chronic Dis 2020;17:200202.
CME ACTIVITY
PEER REVIEWED
Haverkamp D, English K, Jacobs-Wingo J, Tjemsland A, Espey D. Effectiveness of Interventions to Increase Colorectal Cancer Screening Among American Indians and Alaska Natives. Prev Chronic Dis 2020;17:200049.
ORIGINAL RESEARCH
PEER REVIEWED
Soori M, Platz EA, Kanarek N. Inclusion of Evidence-Based Breast Cancer Control Recommendations and Guidelines in State Comprehensive Cancer Control Plans. Prev Chronic Dis 2020;17:200046.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
